Numerical Comparison of Nasal Aerosol Administration Systems for Efficient Nose-to-Brain Drug Delivery

被引:34
作者
Dong, Jingliang [1 ]
Shang, Yidan [1 ]
Inthavong, Kiao [1 ]
Chan, Hak-Kim [2 ]
Tu, Jiyuan [1 ,3 ]
机构
[1] RMIT Univ, Sch Engn, POB 71, Bundoora, Vic 3083, Australia
[2] Univ Sydney, Fac Pharm, Adv Drug Delivery Grp, Sydney, NSW 2006, Australia
[3] Tsinghua Univ, Inst Nucl & New Energy Technol, Minist Educ Adv Reactor Engn & Safety, Key Lab, POB 1021, Beijing 100086, Peoples R China
基金
中国国家自然科学基金; 澳大利亚研究理事会;
关键词
drug administration; nose-to-brain; numerical modelling; olfactory; particle deposition; CENTRAL-NERVOUS-SYSTEM; PARTICLE DEPOSITION; INTRANASAL DELIVERY; AIR-FLOW; DYNAMICS; MODEL; NANOPARTICLE; PERFORMANCE; SUMATRIPTAN; INHALATION;
D O I
10.1007/s11095-017-2280-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose Nose-to-brain drug administration along the olfactory and trigeminal nerve pathways offers an alternative route for the treatment of central nervous system (CNS) disorders. The characterization of particle deposition remains difficult to achieve in experiments. Alternative numerical approach is applied to identify suitable aerosol particle size with maximized inhaled doses. Methods This study numerically compared the drug delivery efficiency in a realistic human nasal cavity between two aerosol drug administration systems targeting the olfactory region: the aerosol mask system and the breath-powered bi-directional system. Steady inhalation and exhalation flow rates were applied to both delivery systems. The discrete phase particle tracking method was employed to capture the aerosol drug transport and deposition behaviours in the nasal cavity. Both overall and regional deposition characteristics were analysed in detail. Results The results demonstrated the breath-powered drug delivery approach can produce superior olfactory deposition with peaking olfactory deposition fractions for diffusive 1 nm particles and inertial 10 mu m. While for particles in the range of 10 nm to 2 mu m, no significant olfactory deposition can be found, indicating the therapeutic agents should avoid this size range when targeting the olfactory deposition. Conclusions The breath-powered bi-directional aerosol delivery approach shows better drug delivery performance globally and locally, and improved drug administration doses can be achieved in targeted olfactory region.
引用
收藏
页数:12
相关论文
共 50 条
[21]   Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery [J].
Battaglia, Luigi ;
Panciani, Pier Paolo ;
Muntoni, Elisabetta ;
Capucchio, Maria Teresa ;
Biasibetti, Elena ;
De Bonis, Pasquale ;
Mioletti, Silvia ;
Fontanella, Marco ;
Swaminathan, Shankar .
EXPERT OPINION ON DRUG DELIVERY, 2018, 15 (04) :369-378
[22]   Nose-to-brain delivery of levetiracetam after intranasal administration to mice [J].
Goncalves, Joana ;
Bicker, Joana ;
Gouveia, Filipa ;
Liberal, Joana ;
Oliveira, Rui Gaetano ;
Alves, Gilberto ;
Falcao, Amilcar ;
Fortuna, Ana .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 564 :329-339
[23]   On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles [J].
Formica, Maria L. ;
Real, Daniel A. ;
Picchio, Matias L. ;
Catlin, Elise ;
Donnelly, Ryan F. ;
Paredes, Alejandro J. .
APPLIED MATERIALS TODAY, 2022, 29
[24]   Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery [J].
Kanazawa, Takanori ;
Fukuda, Mitsuyoshi ;
Suzuki, Naoto ;
Suzuki, Toyofumi .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (141)
[25]   Nose-to-brain peptide delivery - The potential of nanotechnology [J].
Samaridou, Eleni ;
Alonso, Maria Jose .
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (10) :2888-2905
[26]   Microemulsion-Based Media in Nose-to-Brain Drug Delivery [J].
Froelich, Anna ;
Osmalek, Tomasz ;
Jadach, Barbara ;
Puri, Vinam ;
Michniak-Kohn, Bozena .
PHARMACEUTICS, 2021, 13 (02) :1-37
[27]   Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders [J].
Awad, Rania ;
Avital, Avi ;
Sosnik, Alejandro .
ACTA PHARMACEUTICA SINICA B, 2023, 13 (05) :1866-1886
[28]   Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview [J].
Musumeci, Teresa ;
Bonaccorso, Angela ;
Puglisi, Giovanni .
PHARMACEUTICS, 2019, 11 (03)
[29]   Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics [J].
Bourganis, Vassilis ;
Kammona, Olga ;
Alexopoulos, Aleck ;
Kiparissides, Costas .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 128 :337-362
[30]   Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders [J].
Boyuklieva, Radka ;
Pilicheva, Bissera .
BIOMEDICINES, 2022, 10 (07)